Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations (Q44451644)

3 December 2017

title

Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations (English)

1 reference

3 December 2017

main subject

evidence-based medicine

1 reference

Hans-Jürgen Möller

1 reference

3 December 2017

Wolfgang Maier

1 reference

3 December 2017

language of work or name

1 reference

1 February 2010

1 reference

European Archives of Psychiatry and Clinical Neuroscience

3 December 2017

published in

1 reference

3 December 2017

volume

260

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

25-39

1 reference

Calculating the number needed to treat for trials where the outcome is time to an event

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Show me the evidence: using number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Heterogeneity of treatment effects in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00406-009-0070-9

21 January 2018

12 December 2020

State of the art of drug treatment of schizophrenia and the future position of the novel/atypical antipsychotics

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

1 reference

12 December 2020

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

12 December 2020

Relationship between drug company funding and outcomes of clinical psychiatric research

1 reference

12 December 2020

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

1 reference

12 December 2020

Day centres for severe mental illness.

1 reference

12 December 2020

Evidence-based medicine and 'The Cochrane Collaboration'

1 reference

12 December 2020

Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression

1 reference

12 December 2020

[Evidence-based medicine. How to use biomedical literature to solve clinical problems. Italian Group on Evidence-Based Medicine-GIMBE]

1 reference

12 December 2020

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

1 reference

12 December 2020

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

12 December 2020

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

1 reference

12 December 2020

Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia

1 reference

12 December 2020

Reporting of number needed to treat and its difficulties

1 reference

12 December 2020

Meta-analysis: statistical alchemy for the 21st century

1 reference

12 December 2020

Effectiveness of switching antipsychotic medications

1 reference

12 December 2020

STAR*D: what have we learned?

1 reference

12 December 2020

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

1 reference

12 December 2020

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

1 reference

12 December 2020

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

1 reference

12 December 2020

Research designs for studies evaluating the effectiveness of change and improvement strategies

1 reference

12 December 2020

Evidence-based guidelines for anxiety disorders: can they improve clinical outcomes?

1 reference

12 December 2020

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia

1 reference

12 December 2020

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

12 December 2020

An emerging consensus on grading recommendations?

1 reference

12 December 2020

Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?

1 reference

12 December 2020

Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s

1 reference

12 December 2020

Schizophrenia practice guidelines: international survey and comparison.

1 reference

12 December 2020

Testing the validity of cost-effectiveness models

1 reference

12 December 2020

Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review.

1 reference

12 December 2020

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

1 reference

12 December 2020

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

12 December 2020

[Guidelines and the psychology of medical decision making in the treatment of depressive disorders]

1 reference

12 December 2020

How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?

1 reference

12 December 2020

Metaanalyses - highest level of empirical evidence?

1 reference

12 December 2020

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

12 December 2020

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

12 December 2020

How to develop cost-conscious guidelines.

1 reference

12 December 2020

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

12 December 2020

Evidence-based medicine: useful tools for decision making

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

12 December 2020

[Evidence-based medicine. 3. Systematic reviews: a tool for clinical practice, permanent education and health policy decisions. Italian Group on Evidence-Based Medicine-GIMBE]

1 reference

12 December 2020

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

12 December 2020

Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

1 reference

12 December 2020

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature

1 reference

12 December 2020

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

12 December 2020

Placebo-controlled studies in depression: necessary, ethical and feasible

1 reference

12 December 2020

The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment

1 reference

12 December 2020

Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.

1 reference

12 December 2020

Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.

1 reference

12 December 2020

[The National Program for disease management--guidelines under the auspices of the German Medical Association--a method report]

1 reference

12 December 2020

Framework for design and evaluation of complex interventions to improve health

1 reference

12 December 2020

What CATIE found: results from the schizophrenia trial

1 reference

12 December 2020

Grading quality of evidence and strength of recommendations

1 reference

12 December 2020

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder

1 reference

12 December 2020

Do effectiveness ("real world") studies on antipsychotics tell us the real truth?

1 reference

12 December 2020

Developing and implementing clinical guidelines: lessons from the NICE schizophrenia guideline

1 reference

12 December 2020

Evidence-based psychotherapeutics

1 reference

12 December 2020

Ethical aspects of publishing

1 reference

12 December 2020

Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder

1 reference

12 December 2020

Is society losing control of the medical research agenda?

1 reference

12 December 2020

SSRIs versus other antidepressants for depressive disorder

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

1 reference

12 December 2020

Evidence-based treatment for first-episode schizophrenia?

1 reference

12 December 2020

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system

1 reference

12 December 2020

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

1 reference

12 December 2020

A regulatory Apologia--a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants

1 reference

12 December 2020

Effectiveness and efficiency of guideline dissemination and implementation strategies

1 reference

12 December 2020

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

The evidence base of clinical practice guidelines, health technology assessments and patient information as a basis for clinical decision-making

1 reference

12 December 2020

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

12 December 2020

Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ

1 reference

12 December 2020

Day hospital versus admission for acute psychiatric disorders

1 reference

12 December 2020

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

12 December 2020

[Is mental health services research in need of randomised controlled trials?]

1 reference

12 December 2020

How can we realize the promise of personalized antidepressant medicines?

1 reference

12 December 2020

Origin and funding of the most frequently cited papers in medicine: database analysis

1 reference

12 December 2020

Evidence-based medicine and psychiatric practice.

1 reference

12 December 2020

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

12 December 2020

Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.

1 reference

12 December 2020

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia

1 reference

12 December 2020

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force

1 reference

12 December 2020

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

1 reference

12 December 2020

Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany

1 reference

12 December 2020

Pharmacological and psychological treatments for depressed older patients: a meta-analysis and overview of recent findings

1 reference

12 December 2020

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs

1 reference

12 December 2020

Design of clinical trials of antidepressants: should a placebo control arm be included?

1 reference

12 December 2020

Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales

1 reference

12 December 2020

[From evidence-based medicine to medicine-based evidence]

1 reference

12 December 2020

Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials

1 reference

12 December 2020

Medication augmentation after the failure of SSRIs for depression.

1 reference

12 December 2020

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis

1 reference

12 December 2020

Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.

1 reference

12 December 2020

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

12 December 2020

Supported housing for people with severe mental disorders.

1 reference

12 December 2020

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group

1 reference

12 December 2020

The NICE cost-effectiveness threshold: what it is and what that means

1 reference

12 December 2020

Rating the strength of scientific evidence: relevance for quality improvement programs

1 reference

12 December 2020

Results of phase 3 of the CATIE schizophrenia trial

1 reference

12 December 2020

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

12 December 2020

Incorporation of uncertainty in health economic modelling studies

1 reference

12 December 2020

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

1 reference

12 December 2020

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

12 December 2020

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study

1 reference

12 December 2020

The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis.

1 reference

12 December 2020

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol

1 reference

12 December 2020

Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998.

1 reference

12 December 2020

Algorithms for optimizing the treatment of depression: making the right decision at the right time

1 reference

12 December 2020

What is evidence-based medicine and the role of the systematic review: the revolution coming your way.

1 reference

12 December 2020

Declaration of conflicts of interest in scientific publications.

1 reference

12 December 2020

Methodology and Reports of Systematic Reviews and Meta-analyses

1 reference

12 December 2020

Randomisation to protect against selection bias in healthcare trials

1 reference

12 December 2020

The STAR*D Project results: a comprehensive review of findings.

1 reference

12 December 2020

Recent progress in pharmacological and non-pharmacological treatment options of major depression

1 reference

12 December 2020

Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review

1 reference

12 December 2020

Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.

1 reference

12 December 2020

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

1 reference

12 December 2020

Does evidence-based medicine apply to psychiatry?

1 reference

12 December 2020

A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression.

1 reference

12 December 2020

Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants

1 reference

12 December 2020

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

1 reference

12 December 2020

Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

1 reference

12 December 2020

Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement

1 reference

12 December 2020

Clozapine in treatment-resistant schizophrenics

1 reference

12 December 2020

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report

1 reference

12 December 2020

10.1007/S00406-009-0070-9

Identifiers

DOI

1 reference

3 December 2017

1 reference